Teng, Renli
CareCeutics LLC,
United States
2024 Rank: 140251
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1329 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 140251 | 149229 |
| Total Cites | 3670 | 4200 |
| H-index | 31 | 32 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 143 | 149 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1209 | 1361 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1530 | 1743 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2363 | 2585 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.62 |
| Self-Citation Percentage |
12.62%
|
|
Teng, Renli
Careceutics LLC,
United States
2023 Rank: 143433
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1390 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 143433 | 149382 |
| Total Cites | 3491 | 4013 |
| H-index | 29 | 30 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 124 | 130 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1137 | 1289 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1437 | 1650 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2230 | 2446 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.64 |
| Self-Citation Percentage |
13.01%
|
|
Teng, Renli
AstraZeneca,
United States
2022 Rank: 145110
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1416 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145110 | 147765 |
| Total Cites | 3244 | 3763 |
| H-index | 28 | 30 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 102 | 108 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1059 | 1211 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1338 | 1551 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2055 | 2268 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.66 |
| Self-Citation Percentage |
13.79%
|
|
Teng, Renli
AstraZeneca,
United States
2021 Rank: 145164
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1443 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145164 | 146599 |
| Total Cites | 3113 | 3626 |
| H-index | 27 | 29 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 96 | 102 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1021 | 1173 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1286 | 1499 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1962 | 2174 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.67 |
| Self-Citation Percentage |
14.15%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.